10.21147/j.issn.1000-9604.2022.05.01
National guidelines for diagnosis and treatment of malignant lymphoma 2022 in China(English version)
1.Overview
Lymphoma is one of the most common malignancies in China.According to the report from the World Health Organization(WHO)GLOBOCAN 2020,there were 6,829 new cases of Hodgkin lymphoma(HL)in China in 2020,including 4,506 males and 2,323 females;and 2,807 deaths,including 1,865 males and 942 females.In 2020,92,834 cases of non-Hodgkin lymphoma(NHL)were reported in China,including 50,125 cases in males and 42,709 cases in females;54,351 cases of death were reported,including 29,721 cases in males and 24,630 cases in females.
national、lymphoma、english、china、diagnosis、guidelines、malignant、treatment、version
34
S;R733.1;H313
2022-12-15(万方平台首次上网日期,不代表论文的发表时间)
共22页
425-446